Literature DB >> 12209728

Contrast-enhanced dynamic computed tomography for the evaluation of tumor angiogenesis in patients with lung carcinoma.

Ukihide Tateishi1, Masahiko Kusumoto, Hiroshi Nishihara, Kazuo Nagashima, Toshiaki Morikawa, Noriyuki Moriyama.   

Abstract

BACKGROUND: The objective of this study was to investigate the role of contrast-enhanced dynamic computed tomography (CT) in the evaluation of tumor angiogenesis in patients with lung carcinoma and to assess its importance in predicting tumor size and lymph node involvement.
METHODS: Dynamic CT scans were evaluated retrospectively in 130 patients with primary lung carcinoma who did not have distant metastasis and who underwent surgical resection with mediastinal lymph node dissection. Histopathologic findings of vascular endothelial growth factor (VEGF) expression and microvessel density (MVD) were correlated with the maximum attenuation values of time-attenuation curves (MAV) on dynamic CT scans.
RESULTS: The MAV in VEGF positive tumors was greater compared with the MAV in VEGF negative tumors (66.1 +/- 4.6 vs. 30.9 +/- 2.7, respectively; P < 0.0001). An association was found between the MAV in VEGF positive tumors and MVD (correlation coefficient = 0.650; P < 0.0001). No difference was found in tumor size with pathologic confirmation and the MAV, VEGF expression, or MVD. The MAV, VEGF expression, and MVD in lung tumors with lymph node involvement were greater compared with the same values in lung tumors without lymph node involvement.
CONCLUSIONS: The MAV of dynamic CT may be a predictor of tumor angiogenesis in patients with lung carcinoma and lymph node involvement. Copyright 2002 American Cancer Society.DOI 10.1002/cncr.10730

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12209728     DOI: 10.1002/cncr.10730

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  26 in total

Review 1.  Dynamic contrast-enhanced imaging techniques: CT and MRI.

Authors:  J P B O'Connor; P S Tofts; K A Miles; L M Parkes; G Thompson; A Jackson
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

Review 2.  CAD (computed-aided detection) and CADx (computer aided diagnosis) systems in identifying and characterising lung nodules on chest CT: overview of research, developments and new prospects.

Authors:  F Fraioli; G Serra; R Passariello
Journal:  Radiol Med       Date:  2010-01-15       Impact factor: 3.469

3.  Functional CT imaging techniques for the assessment of angiogenesis in lung cancer.

Authors:  Thomas Henzler; Jingyun Shi; Hashim Jafarov; Stefan O Schoenberg; Christian Manegold; Christian Fink; Gerald Schmid-Bindert
Journal:  Transl Lung Cancer Res       Date:  2012-03

Review 4.  Tracer-kinetic modeling of dynamic contrast-enhanced MRI and CT: a primer.

Authors:  Michael Ingrisch; Steven Sourbron
Journal:  J Pharmacokinet Pharmacodyn       Date:  2013-04-06       Impact factor: 2.745

5.  Vasculature surrounding a nodule: A novel lung cancer biomarker.

Authors:  Xiaohua Wang; Joseph K Leader; Renwei Wang; David Wilson; James Herman; Jian-Min Yuan; Jiantao Pu
Journal:  Lung Cancer       Date:  2017-10-27       Impact factor: 5.705

6.  Tumor angiogenesis and dynamic CT in colorectal carcinoma: radiologic-pathologic correlation.

Authors:  Zi-Ping Li; Quan-Fei Meng; Can-Hui Sun; Da-Sheng Xu; Miao Fan; Xu-Feng Yang; Dong-Ying Chen
Journal:  World J Gastroenterol       Date:  2005-03-07       Impact factor: 5.742

7.  Texture analysis of advanced non-small cell lung cancer (NSCLC) on contrast-enhanced computed tomography: prediction of the response to the first-line chemotherapy.

Authors:  Marco Ravanelli; Davide Farina; Mauro Morassi; Elisa Roca; Giuseppe Cavalleri; Gianfranco Tassi; Roberto Maroldi
Journal:  Eur Radiol       Date:  2013-07-09       Impact factor: 5.315

8.  Functional imaging of lung cancer using dual energy CT: how does iodine related attenuation correlate with standardized uptake value of 18FDG-PET-CT?

Authors:  G Schmid-Bindert; Thomas Henzler; T Q Chu; M Meyer; J W Nance; U J Schoepf; D J Dinter; P Apfaltrer; R Krissak; C Manegold; S O Schoenberg; C Fink
Journal:  Eur Radiol       Date:  2011-08-07       Impact factor: 5.315

9.  Can perfusion CT assessment of primary colorectal adenocarcinoma blood flow at staging predict for subsequent metastatic disease? A pilot study.

Authors:  Vicky Goh; Steve Halligan; David M Wellsted; Clive I Bartram
Journal:  Eur Radiol       Date:  2008-08-15       Impact factor: 5.315

Review 10.  Clinical biomarkers of angiogenesis inhibition.

Authors:  Aaron P Brown; Deborah E Citrin; Kevin A Camphausen
Journal:  Cancer Metastasis Rev       Date:  2008-09       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.